Australia markets closed

Shandong Boan Biotechnology Co., Ltd. (UJ9.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.1500+0.0100 (+0.88%)
At close: 03:29PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-119,377
-119,377
-331,749
-225,417
-240,538
Depreciation & amortisation
82,766
82,766
72,835
50,009
15,882
Stock-based compensation
20,640
20,640
18,479
21,275
0
Change in working capital
-18,330
-18,330
33,435
-99,658
-292,699
Inventory
-21,657
-21,657
-44,794
-79,168
-17,116
Other working capital
-313,326
-313,326
-408,217
-587,523
-637,996
Other non-cash items
12,928
12,928
7,839
2,498
10,624
Net cash provided by operating activities
-18,568
-18,568
-201,841
-246,278
-506,720
Cash flows from investing activities
Investments in property, plant and equipment
-294,758
-294,758
-206,376
-341,245
-131,276
Purchases of investments
-
-
-
-100,000
0
Sales/maturities of investments
0
0
100,000
-
-
Net cash used for investing activities
-293,571
-293,571
-100,684
-432,296
-18,787
Net change in cash
-29,053
-29,053
-302,652
533,155
1,726
Cash at beginning of period
233,498
233,498
531,703
3,629
1,903
Cash at end of period
201,850
201,850
233,498
531,703
3,629
Free cash flow
Operating cash flow
-18,568
-18,568
-201,841
-246,278
-506,720
Capital expenditure
-294,758
-294,758
-206,376
-341,245
-131,276
Free cash flow
-313,326
-313,326
-408,217
-587,523
-637,996